Jeffrey Young Email

Chief Financial Officer . Axial Therapeutics

Current Roles

Employees:
28
Revenue:
$4.3M
About
Axial Therapeuticsâ„¢ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. The company is leveraging its expertise in the gut-brain axis and its unique drug development platform to advance novel therapies that have the potential to transform the treatment paradigm in neurodegenerative diseases.
Axial Therapeutics Address
400 Tradecenter Drive
Waltham, MA
United States
Axial Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.